ReproCELL Incorporated
4978.T · JPX
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Revenue | ¥3 | ¥2 | ¥3 | ¥2 |
| % Growth | 22.7% | -17.8% | 32.2% | – |
| Cost of Goods Sold | ¥1 | ¥1 | ¥2 | ¥1 |
| Gross Profit | ¥2 | ¥1 | ¥1 | ¥1 |
| % Margin | 55.3% | 46.2% | 38.6% | 36% |
| R&D Expenses | ¥1 | ¥0 | ¥1 | ¥1 |
| G&A Expenses | ¥1 | ¥1 | ¥1 | ¥1 |
| SG&A Expenses | ¥1 | ¥1 | ¥1 | ¥1 |
| Sales & Mktg Exp. | ¥0 | -¥0 | ¥0 | ¥0 |
| Other Operating Expenses | ¥0 | ¥0 | ¥0 | ¥0 |
| Operating Expenses | ¥2 | ¥2 | ¥1 | ¥1 |
| Operating Income | -¥0 | -¥0 | -¥0 | -¥1 |
| % Margin | -4.4% | -16.9% | -12.1% | -29% |
| Other Income/Exp. Net | ¥0 | ¥0 | ¥0 | ¥0 |
| Pre-Tax Income | ¥0 | -¥0 | -¥0 | -¥1 |
| Tax Expense | -¥0 | ¥0 | ¥0 | ¥0 |
| Net Income | ¥0 | -¥0 | -¥0 | -¥1 |
| % Margin | 3.5% | -1.3% | -10.3% | -25.7% |
| EPS | 1.11 | -0.37 | -3.62 | -7.57 |
| % Growth | 400% | 89.8% | 52.2% | – |
| EPS Diluted | 1.11 | -0.37 | -3.62 | -7.57 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | ¥0 | ¥0 | ¥0 | ¥0 |
| Interest Expense | ¥0 | ¥0 | ¥0 | ¥0 |
| Depreciation & Amortization | ¥0 | ¥0 | ¥0 | ¥0 |
| EBITDA | ¥0 | ¥0 | -¥0 | -¥1 |
| % Margin | 3.2% | 0.3% | -8.6% | -23% |